Pharmaceutical economics, also known as pharmacoeconomics, deals with supply and demand of pharmaceutical products, as well as the cost-benefit evaluation of new and existing drugs. Primary concerns of the field include expanding drug accessibility, reducing the price of drugs and improving the cost-effectiveness of new drug therapies. Professionals in this field have proficient understanding of healthcare policy, healthcare administration and drug regulations, coupled with strong mathematical skills. It is a sub-discipline of health economics. A pharmacoeconomic study evaluates the cost (expressed in monetary terms) and effects (expressed in terms of monetary value, efficacy or enhanced quality of life) of a pharmaceutical product. The information can be published in our peer reviewed journal with impact factors and are calculated using citations not only from research articles but also review articles (which tend to receive more citations), editorials, letters, meeting abstracts, short communications, and case reports. The inclusion of these publications provides the opportunity for editors and publishers to manipulate the ratio used to calculate the impact factor and try to increase their number rapidly. Impact factor plays a major role for the particular journal. Journal with higher impact factor is considered to be more important than other ones.